Want to join the conversation?
$GILD 2Q15 Call: Pleased with the number of patients GILD is reaching with Sovaldi and Harvoni, which are now approved in 51 and 40 countries, respectively. Total HCV revenue was $4.9Bil. US HCV product revenue was $3.4Bil, of which Harvoni represented $2.8Bil. In 1H15, estimated 130K US hepatitis C patients started treatment on a Gilead product.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.